The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Balan V.E.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

LNG-IUD as postpartum contraceptive method: validity of the choice

Authors:

Balan V.E.

More about the authors

Journal: Russian Journal of Human Reproduction. 2016;22(4): 95‑101

DOI: 10.17116/repro201622495-101

Read: 967 times

Download PDF (RU)
Contact the author
Table of contents

LNG-IUD AS POSTPARTUM CONTRACEPTIVE METHOD: VALIDITY OF THE CHOICE
LNG-IUD AS POSTPARTUM CONTRACEPTIVE METHOD: VALIDITY OF THE CHOICE

To cite this article:

Balan VE. LNG-IUD as postpartum contraceptive method: validity of the choice. Russian Journal of Human Reproduction. 2016;22(4):95‑101. (In Russ.)
https://doi.org/10.17116/repro201622495-101

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Prevention of unintended pregnancy in the postnatal period by complete woman’s rehabilitation remains the key problem which decision is possible only with using the reliable and safe contraceptive methods giving to women opportunity of a conscious choice of terms of the subsequent pregnancy. The levonorgestrel intrauterine system (LNG-IUD) Mirena has advantages of intrauterine contraception and hormonal contraception providing multiple protection against undesirable pregnancy with minimal system effect in general. LNG-IUD has no adverse effect on breast-feeding performance and infant development. Prevalence of unintended pregnancy with correct and timely mirena insertion after the delivery is no more than 0.1%.

Keywords:

postpartum contraception
Long-Acting Reversible Contraception (LARC)
levonorgestrel intrauterine system (LNG-IUD)

Authors:

Balan V.E.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Close metadata

References:

  1. Grimes DA. Forgettable contraception. Contraception. 2009;80:497-499.  doi: 10.1016/j.contraception.2009.06.005
  2. American College of Obstetricians and Gynecologists. Long-acting reversible contraception: implants and intrauterine devices. Practice Bulletin No. 121. Obstet Gynecol. 2011;118:184-196.  doi: 10.1097/AOG.0b013e318227f05e
  3. Quinn GP. Improving family planning with the use of long-acting reversible contraception use. Fertil Steril. 2016;105(2):304.  doi: 10.1016/j.fertnstert.2015.11.029
  4. Gavin L, Moskosky S, Carter M, et al. Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recomm Rep. 2014;63:1-54.
  5. Prilepskya VN, Tagieva AV, Mezhevitinova А. Intrauterine contraception. M.: GEOTAR-Media Publishing Group. 2010;176. (In Russ.).
  6. Mosher WD, Moreau C, Lanto H. Trends and determinants of IUD use in the USA, 2002-2012. Hum Reprod. 2016. doi: 10.1093/humrep/dew117 First published online: May 31, 2016
  7. World Health Organization. Postpartum care of the mother and newborn: a practical guide. Geneva: WHO; 1998. Available at: http://apps.who.int/iris/bitstream/ 10665/66439/1/WHO_RHT_MSM_98.3.pdf. Retrieved February 17, 2016
  8. Aber C, Weiss M, Fawcett J. Contemporary women’s adaptation to motherhood: the first 3 to 6 weeks postpartum. Nurs Sci Q. 2013;26:344-351.  doi: 10.1177/0894318413500345
  9. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA. 2006;295:1809-1823. doi: 10.1001/jama.295.15.1809
  10. Grisaru-Granovsky S, Gordon ES, Haklai Z, et al. Effect of interpregnancy interval on adverse perinatal outcomes - a national study. Contraception. 2009;80:512-518.  doi: 10.1016/j.contraception.2009.06.006. Epub 2009 Jul 22
  11. Guidelines on contraception. Ed. Prilepskya V.N. M.: MEDpress. 2006;110-180. (In Russ.).
  12. Chernukha EA. Normal and pathological postnatal period: management. M.: GEOTAR-Media Publishing Group. 2006;271. (In Russ.).
  13. Dobrokhotova YE, Mandrykina ZhA. Postnatal contraception. Rossijskij-vestnik-akushera-ginekologa. 2012;4:99-103. (In Russ.).
  14. Mikhaylova OI, Skripnichenko YuP,Yakushevskaya OV. Effective Postnatal contraception. RMJ (Mother and child. Obstetrics and gynecology). 2013;1. (In Russ.).
  15. Levi E, Cantillo E, Ades V, et al. Immediate postplacental IUD insertion at cesarean delivery: a prospective cohort study. Contraception. 2012;86:102e5. doi: 10.1016/j.contraception.2011.11.019. Epub 2012 Jan 20
  16. Jatlaoui TC, Marcus M, Jamieson DJ, et al. Postplacental intrauterine device insertion at a teaching hospital. Contraception. 2014;89:528e33. doi: 10.1016/j.contraception.2013.10.008. Epub 2013 Oct 23
  17. Grimes D, Schulz K, van Vliet H, Stanwood N. Immediate postpartum insertion of intrauterine devices. Cochrane Database Syst Rev. 2010;D003036. doi: 10.1002/14651858.CD003036.pub2
  18. Lopez LM, Bernholc A, Hubacher D, et al. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database Syst Rev. 2015;(6):CD003036. doi: 10.1002/14651858.CD003036.pub3
  19. Sonalkar S, Kapp N. Intrauterine device insertion in the postpartum period: a systematic review. Eur J Contracept Reprod Health Care. 2015;20:4e18. doi: 10.3109/13625187.2014.971454. Epub 2014 Nov 14
  20. Washington CI, Jamshid R, Thung SF. Timing of postpartum intrauterine device placement: a cost-effectiveness analysis. Fertil Steril. 2015;103:131-137.  doi: 10.1016/j.fertnstert.2014.09.032. Epub 2014 Oct 25
  21. Whitaker AK, Endres LK, Mistretta SQ, Gilliam ML. Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial. Contraception. 2014;89:534e9. doi: 10.1016/j.contraception.2013.12.007. Epub 2013 Dec 26
  22. Eroglu K, Akkuzu G, Vural G, et al. Comparison of efficacy and complications of IUD insertion immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception. 2006;74:376-381.  doi: 10.1016/j.contraception.2006.07.003
  23. Dahlke JD, Terpstra ER, Ramseyer AM, et al. Postpartum insertion of levonorgestrel-intrauterine system at three time periods:a prospective randomized pilot study. Contraception. 2011;84:244-248.  doi: 10.1016/j.contraception.2011.01.007. Epub 2011 Feb 24
  24. Chen BA, Reeves MF, Hayes JL, et al. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized control trial. Obstet Gynecol. 2010;116:1079-1087. doi: 10.1097/AOG.0b013e3181f73fac
  25. Ragab A, Hamed HO, Alsammani MA, et al. Expulsion of Nova-T380, multoload 375 and copper-T380A contraceptive devices inserted during cesarean section. Int J Gynecol Obstet. 2015;130:174-178.  doi: 10.1016/j.ijgo.2015.03.025. Epub 2015 May 6
  26. Wildemeersch D, Goldstuck ND, Hasskamp T. Current status of frameless anchored IUD for immediate intracesarean insertion. Dev Period Med. 2016;20:7-15.
  27. WHO Medical Eligibility Criteria for contraceptive use, 5th edition, 2015. www.who.int/reproductivehealth/publications/family_planning
  28. Reid R, Roy G, Varto H, et al. Canadian Contraception Consensus (Part 3 of 4). Chapter 7 Intrauterine Contraception. No. 329, February 2016. J Obstet Gynaecol Can. 2016;38(2):182-222.  doi: http://dx.doi.org/10.1016/j.jogc.2015.12.002
  29. World Health Organization. The Optimal Duration of Exclusive Breastfeeding. Geneva, Switzerland: WHO. 2001.
  30. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev. 2012;8:Cd003517. doi: 10.1002/14651858.CD003517.pub2
  31. Borda MR, Winfrey W, McKaig C. Return to sexual activity and modern family planning use in the extended postpartum period: an analysis of findings from seventeen countries. Afr J Reprod Health. 2010;14:72-79.
  32. Phillips SJ, Tepper NK, Kapp N, et al. Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception. 2015 Article in Press. doi: http://dx.doi.org/10.1016/j.contraception.2015.05.006
  33. Chen BA, Reeves MF, Creinin MD, Schwarz EB. Postplacental or delayed levonorgestrel intrauterine device insertion and breast-feeding duration. Contraception. 2011;84(5):499-504.  doi: 10.1016/j.contraception.2011.01.022. Epub 2011 Apr 16
  34. Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de S· MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009;80(6):519-526.  doi: 10.1016/j.contraception.2009.05.124. Epub 2009 Jul 10
  35. Gurtcheff SE, Turok DK, Stoddard G, Murphy PA, Gibson M, Jones KP. Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial. Obstet Gynecol. 2011;117(5):1114-1121. doi: 10.1097/AOG.0b013e3182165ee8
  36. Bahamondes L, Bahamondes MV, Modesto W, Tilley IB, Magalhaes A, Pinto e Silva JL, et al. Effect of hormonal contraceptives during breastfeeding on infant’s milk ingestion and growth. Fertil Steril. 2013;100(2):445-450.  doi: 10.1016/j.fertnstert.2013.03.039. Epub 2013 Apr 23
  37. Shaamash AH, Sayed GH, Hussien MM, Shaaban MM. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Contraception. 2005;72(5):346-351.  doi: http://dx.doi.org/10.1016/j.contraception.2005.04.004
  38. Andreeva EN. Tolerability and patient satisfaction using different intrauterine contraceptive: results of the observation program MIRABEL. Gynecology. 2015;17(5):37-43. (In Russ.).
  39. ACOG Committee opinion no. 392: intrauterine device and adolescents. Obstet Gynecol. 2007;110:1493-1495.
  40. Yen S, Saah T, Hillard PJ. IUDs and adolescents - an under-utilized opportunity for pregnancy prevention. J Pediatr Adolesc Gynecol. 2010;23(3):123-128.  doi: 10.1016/j.jpag.2009.09.004. Epub 2009 Nov 5
  41. Deans EI, Grimes DA. Intrauterine devices for adolescents: a systematic review. Contraception. 2009;79(6):418-423.  doi: 10.1016/j.contraception.2008.12.009. Epub 2009 Feb 7
  42. Mestad R, Secura G, Allsworth JE, et al. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception. 2011;84:493498. doi: 10.1016/j.contraception.2011.03.001. Epub 2011 Apr 27
  43. Bayer LL, Jensen JT, Li H, et al. Adolescent experience with intrauterine device insertion and use: a retrospective cohort study. Contraception. 2012;86:443-451.  doi: 10.1016/j.contraception.2012.03.014. Epub 2012 May 4
  44. Alton TM, Brock GN, Yang D, et al. Retrospective review of intrauterine device in adolescent and young women. J Pediatr Adolesc Gynecol. 2012;25:195-200.  doi: 10.1016/j.jpag.2012.01.005
  45. Abraham M, Zhao Q, Peipert J. Young Age, Nulliparity, and Continuation of Long-Acting Reversible Contraceptive Methods. Obstet Gynecol. 2015;126:823-829.  doi: 10.1097/AOG.0000000000001036
  46. Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105-1113. doi: 10.1097/AOG.0b013e31821188ad
  47. Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol. 2012;120:1298-1305. doi: http://10.1097/AOG.0b013e31827499bd
  48. Black K, Lotke P, Buhling KJ, et al. A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women. Eur J Contracept Reprod Health Care. 2012;17:340-350.  doi: 10.3109/13625187.2012.700744. Epub 2012 Jul 26
  49. Bahamondes MV, Hidalgo MM, Bahamondes L, et al. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception. 2011;84:e11-e16.  doi: 10.1016/j.contraception.2011.05.012. Epub 2011 Jun 25
  50. Baldwin MK, Edelman AB. The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: a review. J Adolesc Health. 2013;52:S47-S53.  doi: 10.1016/j.jadohealth.2012.10.278
  51. Nerlander LM, Callaghan WM, Smith RA, Barfield WD. Short interpregnancy interval associated with preterm birth in US adolescents. Matern Child Health J. 2015;19:850-85.  doi: 10.1007/s10995-014-1583-z
  52. Cohen R, Sheeder J, Arango N, et al. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing post-delivery contraceptive implants or postplacental intrauterine devices. Contraception. 2016;93:178-83.  doi: 10.1016/j.contraception.2015.10.001. Epub 2015 Oct 22
  53. Centers for Disease Control and Prevention. Reproductive life plan tool for health professionals. Available at: http://www.cdc.gov/preconception/rlptool.html. Retrieved February 17, 2016.
  54. National Institute for Health and Care Excellence. Postnatal care. NICE Quality Standard QS37. London: NICE; 2013. Available at: https://www.nice.org.uk/guidance/qs37. Retrieved February 19, 2016.
  55. ACOG COMMITTEE OPINION. Number 666. Committee on Obstetric Practice. Optimizing Postpartum Care. Obstet Gynecol. 2016;127(6):187-192.  doi: 10.1097/AOG.0000000000001487
  56. Blumenthal PD, Voedisch A, Gemzell-Danielsson K. Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception. Hum Reprod Update. 2010;17(1):121-137.  doi: 10.1093/humupd/dmq026. Epub 2010 Jul 15
  57. Institute of Medicine. Report Brief. Institute of Medicine of the National Academies; Jun, 2009. [September 30, 2011]. Initial national priorities for comparative effectiveness research. www.iom.edu/cerpriorities.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.